- In June 2023, EUROIMMUN Medizinische Labordiagnostika AG (Germany), a Revvity company, launched the UNIQO 160, an advanced automated indirect immunofluorescence test (IIFT) system. This system automates the entire IIFT process—from sample preparation to image analysis—enhancing diagnostic efficiency and reliability in autoimmune disease testing
- In May 2023, Thermo Fisher Scientific introduced the Autoimmune Assay Kit, designed to provide rapid and accurate results for autoimmune disease detection. This new product aims to improve diagnostic capabilities and patient management
- In March 2023, Trinity Biotech launched the Autoimmune Panel Plus, a diagnostic assay offering enhanced accuracy and speed in detecting various autoimmune diseases. This product significantly improves diagnostic workflows in clinical laboratories
- In June 2022, THERADIAG entered into a partnership with Quotient Limited to advance autoimmune diagnostics by leveraging Quotient's MosaiQ platform. Under this agreement, Theradiag supplies Quotient with autoimmune reagents and quality controls for the development of autoimmune microarrays, with the first application focusing on Connective Tissue Diseases (CTD)
- In May 2022, ZEUS Scientific received FDA clearance for its dIFine digital immunofluorescence system, which is used with ZEUS's ANA HEp-2 indirect fluorescent antibody (IFA) assay. This clearance includes positive and negative determination and eight common ANA HEp-2 staining patterns, contributing to improved diagnostic precision
